Objective. Type 2 diabetes mellitus (T2DM) is characterized by a relative insulin defi ciency or insulin resistance. It is also associated with a cluster of metabolic abnormalities, including hypertension and dyslipidemia. Although there are many studies that have studied the metabolic abnormalities in T2DM patients with metabolic syndrome (MetS), only few of them have assessed the metabolic abnormalities in their fi rst-degree relatives (FDRs) who had MetS. Th e aim of this study is to compare the clinical and biochemical variables in T2DM subjects and their FDRs without diabetes in Benin City, Nigeria.
In 1988, Reaven (1988) had described a multifaceted metabolic abnormality consisting of insulin resistance with compensatory hyperinsulinemia, T2DM, essential hypertension and hypercholesterolemia. Th is syndrome became known as Reaven's syndrome. Th e WHO and International Diabetes Federation (IDF) are using the term "Metabolic Syndrome" to describe this constellation of conditions (Zimmet et al. 2005; WHO 1999) . It is estimated that about 20-25% of the world's population have MetS (IDF 2006) . Its prevalence rates range from 13-30% and 70-80% among the Caucasian non-diabetic (Alberti et al. 2006; IDF 2006) and diabetic (Wellborn and Wearne 1976; Pyorala 1979) populations, respectively. Among African-Americans with T2DM, the prevalence of MetS is estimated to be 70% (Chaiken et al. 1993) . Several theories have been postulated in its pathogenesis; amongst them is the belief that genetically determined insulin resistance in a setting of suitable environmental factors is the pivotal pathogenic mechanism underlying the MetS (Reaven 1988) . Interestingly, persons without diabetes who are relatives of DM patients tend to be insulin resistant (Elbein et al. 1991; Galli et al. 1992; Stewart et al. 1995) . It is also thought that lipoprotein lipase deficiency largely accounts for the lipid abnormalities in MetS patients (Verges 1999) , while the hypertension is due to enhanced sympathetic activities, salt sensitivity, and increased transmembrane cation transport (Ginner et al. 2001; Rosolova 2003) . In addition, the role of tumor necrosis factor in obesity and insulin resistance has also been described (Hotamisligil 1999) . It is noteworthy to say that developing nations are witnessing rapid industrialization, urbanization, and increasing economic prosperity. Th e gradual adoption of western lifestyle, which is characterized by calorie excess and physical inactivity, provide suitable milieu for the development of the MetS in genetically predisposed individuals.
It is also important to note that MetS and DM have some features in common, including central obesity, insulin resistance, dyslipidemia, and increased risk for cardiovascular events. In addition, FDR of persons with T2DM may also be at increased risk for developing the MetS (Siewert et al. 2007 
Subjects and Methods
Subjects. Before commencement of the study, ethical approval was sought from the Ethics and Research Committee of the University of Benin Teaching Hospital, Benin City, Nigeria. Consent was obtained verbally in the best understood language of the patient (with an interpreter if the patient did not understand English) and this was documented appropriately in the questionnaire. Th e Ethics and Research committee of the University of Benin Teaching Hospital approved both the study and consent procedure.
Th is was a cross sectional case control study carried out at the Diabetes Clinic of the University of Benin Teaching Hospital (UBTH), a 500 bed Federal Government tertiary hospital in Benin City, Edo State located in the South-south geopolitical region of Nigeria. Th e UBTH receives referral cases from various parts of Edo State and other neighboring States like Delta, Ondo, Ekiti and Kogi States including Abuja, the Federal Capital Territory. Totally, 124 subjects were recruited from the Diabetes Clinic of the UBTH using the convenience sampling method. Th e inclusion criteria included people diagnosed as having T2DM who presented to UBTH within the last 24 months using the 1999 WHO criteria (Table 1) (Trinder 1969) , people aged 30 years and above, on treatment with oral hypoglycemic drugs plus or minus non-pharmacological therapy and not requiring insulin for survival and fi nally those who consented to participate in the study. Exclusion criteria included 1) subjects diagnosed of having other types of DM, 2) those with T2DM and aged < 30 years, and 3) subjects who declined being a part of the study. For FDR (who do not have diabetes) of persons with T2DM, 96 subjects were recruited from the T2DM patients. Th e inclusion criteria included 1) FDR of a diagnosed T2DM patient, 2) 30 years old and above old subjects, 3) subjects that did not have DM and 4) fi nally those who consented to the study while the exclusion criteria included FDR diagnosed with DM and those that declined being a part of the study. For control subjects, 96 subjects were recruited from the staff of UBTH and healthy relatives of patients without diabetes using the convenience sampling method. Th e inclusion criteria included age and sex matched adult who did not have diabetes with fasting plasma glucose less than 110 mg/dl while the exclusion criteria included persons without diabetes less than 30 years of age, FDR of T2DM subjects and fi nally persons without diabetes who declined to participate in the study.
Th e following parameters were assessed: anthropometric indices, blood pressure, serum lipid profi le, fasting plasma glucose (Trinder 1969; WHO 1995) . Anthropometric measurements of weight, height, waist circumference (WC), and hip circumference (HC) were measured in each subject. Th e weight (Wt) was measured in subjects in light clothing, without shoes using a weighing scale and recorded in kilograms (kg) measured to the nearest 0.1 kg. Th e height (Ht) was measured without shoes and the subject standing upright and looking straight ahead (along the coronal plane) using a stadiometer (RGZ-160 by Pyrochy Medical England) and was recorded to the nearest 0.1 cm. Th e body mass index (BMI) was calculated by the formula: BMI=Weight (kg)/Height 2 (m). Th e WC was taken at the point midway between the inferior margin of the rib cage and the iliac crest to the nearest 0.1 cm using the measuring tape. Th e HC was measured at the level of the maximal gluteal circumference (along the greater trocanter) to the nearest 0.1 cm with subjects standing erect, hands at the sides and feet together. Th e waist: hip ratio (WHR) was thereaft er determined as the WC divided by the HC. Th e blood pressure (BP) was measured to the nearest 2 mmHg using a standard mercury sphygmomanometer (Accoson UK) with subjects in the sitting position and the arms resting on the arms of a chair and the sphygmomanometer at the level of the heart using the 1st and 4th Korotkoff sounds for the systolic BP (SBP) and diastolic BP (DBP) respectively. A fi rst-degree relative was defi ned in this study to be a parent, off spring or sibling of a diabetic patient.
Laboratory investigations.
All subjects were instructed to perform an overnight fast (8-10 h) before the day of sample collection. About 20 ml of blood was collected from the ante-cubital vein using sterile disposable needles and syringes for the following investigations. Two ml of blood was collected in fl uoride oxalate bottles and then analyzed for plasma glucose within 1 h by the glucose oxidase method.
For the analysis of serum lipid profi le, blood was collected in plain bottles (sample bottles that have no anticoagulant with a standard solid yellow cap) allowed to clot and the serum separated and stored at -20°C until analyzed. Th e assay was done by enzymatic method using Randox Kit. Assays were carried out reasonably promptly during the course of this study.
Approximately 1 ml of blood was collected for hemoglobin A1c assay using the D-10 machine. Th e D-10 Test was made based on chromatographic separation of HbA1c on a cation exchange cartridge. Separation was optimized to minimize interferences from hemoglobin variants, labile A1c, and carbamylated hemoglobin. It utilized the principles of ionexchange high-performance liquid chromatography (HPLC). Th e samples were automatically diluted on the D-10 and injected into the analytical cartridge. Th e D-10 delivered a programmed buff er gradient of increasing ionic strength to the cartridge, where the hemoglobins were separated based on their ionic interactions with the cartridge material. Th en, the separated hemoglobins passed through the fl ow cell of the fi lter photometer, where changes in the absorbance at 415 nm were measured. Th e soft ware performed a reduction of the raw data collected from each analysis. Two-level calibration was used for quantifi cation of the HbA1c values. A sample report and chromatogram were generated for each sample. Th e A1c peak was shaded. Th is area was calculated using an exponentially modifi ed Gaussian (EMG) algorithm that excludes the labile A1c and carbamylated peak areas from the A1c peak area.
Statistical analysis. Th e data obtained were analyzed using the statistical soft ware-Statistical package for social sciences [SPSS] version 16. Statistical comparisons were made with student's t-test for quantitative variables and the Chi-square test was used for comparison of proportions. A p-value of less than 0.05 was taken as statistically signifi cant. Th e student t-test was used to compare means and test for signifi cant diff erences in the anthropometric and the metabolic indices. Th ree hundred and twenty fi ve persons were enrolled for this study (125 persons living with T2DM, 102 persons who were non-diabetic fi rst degree relatives of T2DM persons and 98 nondiabetic control subjects without a history of DM in a FDR). Out of the 125 persons living with T2DM, 124 met the requirements for inclusion into the stage of analysis. Th e person excluded from the study had incomplete results and an irregularly fi lled questionnaire. Out of the 102 non-diabetic FDR, 6 persons were dropped on account of incomplete data while for the control group, 2 persons were dropped for the same reason. One hundred and twenty four persons with T2DM, 96 non-diabetic FDR and 96 controls met all the requirements and were included in this study. Th e total number of subjects who participated fully in this study was 316.
Results
Of the 96 controls, recruited for the study, 38 (39.6%) were males, while females made up 58 (60.4%) of the control population. Th e mean age for the control group was 58.6±11.2 years. Th e age range was 31-83 years. Majority (over 60%) of the control subjects were within the age range of 50-69 years. Similarly, of the 96 FDR of persons living with T2DM recruited for the study, 38 (39.6%) were males while 58 (60.4%) were females. Th e mean age for this group was 57.4±10.6 years. Th e age range was 30-80 years and the majority (over 60%) of the patients was within the age range of 50-69 years. A further breakdown of the FDRs reveals that siblings were 66 (68.8%), parents were 12 (12.5%), while off spring were 18 (18.7%) of the study group. Out of the 124 persons living with T2DM recruited for the study, males constituted 40.3% of the group population, while the females accounted for 59.7% of the group population. Th e mean age of persons living with T2DM was 57.7±10.8 years. Th e age range was 30-85 years and majority of the subjects fell within the age range of 50-69 years. Statistical analysis comparing the age group distribution yielded no signifi cant diff erence (F=2.107, df=8, p=0.97). Similarly, no signifi cant sex diff erence was observed (F=0.017, df=8, p=0.99) ( Table 2) .
A comparison of the clinical and biochemical variables across the three study populations shows that there was no statistically signifi cant diff erence in the anthropometric measures across the three study populations (Table 2) .
Th e percentage of persons with MetS varied with age. For persons with T2DM, the percentage peaked at the age of 40-49 years thereaft er; it started declining (Figure 1) . Th e FDR group peaked at the age of 40-49 years before declining at the age range of 70 years and above. Th e control group also showed a similar trend of increasing percentage with age, however, a peak was observed in the age range of 40-49. Th e chi square for linear trend was 97.1 with a p-value=0.01. Th is implies there is a linear relationship between age and MetS. Table 4 shows the prevalence of the MetS using the WHO diagnostic criteria. Using the WHO as the gold standard criteria for the diagnosis of the MetS, the prevalence of MetS in the control, FDR and T2DM groups was 13.5%, 16.7% and 87.1%, respectively. Furthermore, more T2DM persons had the MetS than persons in the control or FDR groups. Table 4 shows the number of subjects in the diff erent age groups. Table 5 shows that there was a statistically significant diff erence in their mean HbA1c, triglyceride levels and HDL (p=0.01, 0.01 and 0.03, respectively). Th e waist:hip (WHR) was only signifi cant (p=0.05). No statistically signifi cant diff erences were seen in comparison of other clinical and biochemical indices as shown in Table 5 .
Subjects with MetS in the FDR group were more obese than those with the MetS in the control group and the mean BMI was signifi cantly statistically different. Th e mean of total cholesterol, HDL cholesterol and triglycerides were higher in subjects with MetS in the control group while the LDL cholesterol was higher in subjects with MetS in the FDR group. Th ese fi ndings were however not statistically signifi cant (Table 6) .
Subjects with MetS in the T2DM group had higher mean of HbA1c, FPG, total cholesterol, and LDL than the FDR subjects with MetS (Table 7) ; these were however, not signifi cant, however, HbA1c was signifi cant. Th e subjects in the FDR group with the MetS had a higher DBP, which was also not signifi cant. Th e mean of BMI and SBP were however signifi cantly higher in the FDR subjects with MetS.
Discussion
Th is study revealed that the prevalence of MetS in T2DM subjects and their FDR as defi ned by the WHO criteria was 87.1% and 16.7%, respectively. Several Nigerian studies have reported similar prevalence (Ogbera 2010; Osuji et al. 2012 ) while others have reported lower prevalence (Adediran and Ohwovoviole 2003; Alebiosu and Odusan 2004; Eregie and Edo 2006) . Unlike in our study, these studies did not look at the prevalence of MetS in FDR of T2DM patients with MetS and to the best of our knowledge, this is the fi rst study in our locale that considered eral biochemical abnormalities. Th ese changes are also known to occur in subjects with T2DM but there are few data on changes seen in their FDRs.
Comparing subjects in the control group having MetS with subjects in T2DM group also having MetS, those in T2DM group tended to be more overweighed with more central obesity than subjects with MetS in the control group (p=0.51, 0.05 and 0.71, respectively) (Table 3) . However, no signifi cant diff erence was observed for each of these parameters in the groups, it refl ects some similarity in the groups and these are recognized risk factors for the development of DM. A lifestyle modifi cation strategy will be essential in preventing the development of DM in these persons. Th is picture may also suggest that obesity is a principal factor in the development of both MetS and DM. Subjects with the MetS in the control had higher mean values of SBP and DBP than subjects with MetS in the T2DM group, however, this was not statistical- FDR hence the novelty of this study. It has increasingly been reported that persons without diabetes who are relatives of patients with diabetes also tend to be insulin resistant. Moreover, both genetic and/or non-genetic familial infl uences seem to aff ect the initiation and progression of MetS hence this reported prevalence of FDR of T2DM patients with MetS. Th e prevalence of the MetS among African-Americans with T2DM was reported to be as high as 70% (Chaiken et al. 1993) . Mohsin et al. (2007) reported a prevalence of 86.5% in Islamabad, Pakistan with a higher female prevalence of 95%. Th is may be a result of the relatively sedentary lifestyle of women, in that part of the world, especially due to religious and social barriers. Again, these studies did not consider FDR of their T2DM subjects with MetS unlike in our study. Subjects with MetS are generally known to have increased risk for cardiovascular events; they are also known to be overweight, hypertensive and have sev-ly signifi cant (p=0.08 and 0.24, respectively). Th is difference may be a result of ongoing therapy in persons with T2DM with the aim of reaching the BP target of 130/80 mmHg. Th e higher BP in the control may be the consequence of a higher proportion of sedentary persons reported in this group. Th ese persons are at risk of having cardiovascular events and require lifestyle modifi cation. Th e mean FPG of the control was lower than that of the T2DM group, but this was not statistically signifi cant (p=0.19). On the other hand, the mean HbA1c was signifi cantly higher in the T2DM group (p=0.01). Th is clearly shows that there is preponderance of poor glycemic control among known diabetic patients with MetS. Th e mean total cholesterol was higher in the control group than in T2DM group although this was also not statistically signifi cant (p=0.68). Th e mean value of triglycerides was higher in the control group than in the T2DM group and this was statistically signifi cant (p=0.01). Th is may be a result of unrestricted diet in the control group and a refl ection of ongoing therapy in persons with T2DM. Moreover, during routine clinic visits, diabetic patients are exposed to health education tips on lifestyle modifi cation strategies such as diet intake and exercise which may have contributed to their lower lipid levels. A few of the control subjects were on therapy for hypertension and the eff ects of these anti hypertensives (e.g. diuretics) may refl ect in their mean plasma glucose values.
Comparing subjects with the MetS in the FDR group with control, subjects with MetS in the FDR group tended to be more overweighted, with more central obesity than persons with the MetS in the control; however, the BMI was found to be signifi cantly diff erent. Th is may suggest an inherent familial tendency of being overweight or obese with a resultant development of DM in some family members. Th is fi nding was similar to that by Shaw et al. (1999) who in their study on the relative risks of hyperglycemia, obesity and dyslipidemia in the relatives of patients with T2DM reported that there is a strong familial aggregation of hyperglycemia and obesity in the relatives of subjects with T2DM. Th e subjects in the control group with MetS had a slightly lower mean FPG than persons in the FDR group with MetS. Although the diff erence was not statistically signifi cant, this was unexpected, as previous studies have demonstrated that the FDRs of T2DM patients constitute a high-risk group for DM (Karaman et al. 2012 ). Another study by Ma et al. (2011) on the prevalence of diabetes and pre-diabetes mellitus in FDR of patients with T2DM in Chengdu, China reported high risk of diabetes in FDR of T2DM patients. Th e mean total cholesterol and triglycerides were higher in subjects with the MetS in the control group than that of subjects with the MetS in the FDR group. Th is may be a result of dietary adjustments of the FDR persons because of their potential risk for developing DM. Th ese fi ndings were, however, not signifi cant.
Comparing subjects with MetS in the T2DM group with those in the FDR group, the mean values of WC, FPG, HbA1c, total cholesterol, HDL cholesterol and LDL cholesterol were higher in subjects with MetS in the T2DM group than in persons with MetS in the FDR group. Th ese fi ndings (with the exception of HbA1c which was signifi cant) were, however, not signifi cant. Th e mean values of WHR, BMI, SBP, DBP and triglyceride were higher in persons with the MetS in the FDR group than in persons with the MetS in the T2DM group. Th e diff erence in the BMI and SBP was statistically signifi cant. Th e lower mean Limitations out coming from this study includes 1) we excluded DM in FDRs because we used the WHO criteria which consider DM/pre-diabetes as a prerequisite in making diagnosis, we believe that excluding FDRs of DM patients with metabolic syndrome will give us a better picture of new cases of DM among this group of the study population thereby excluding bias; 2) this was a small study which should be considered exploratory, no multiple comparison adjustments were made in the analysis; therefore a larger and specifi cally designed study is needed to evaluate the clinical and metabolic abnormalities in this group of patients and their FDRs; 3) this study used the WHO criteria which is an old diagnostic criteria, therefore there is a need to perform a larger sample size study with more recent diagnostic criteria; 4) future studies, including measures for proteinuria and microalbuminuria, will give a fuller picture.
Conclusion
Th is study revealed the unacceptably high prevalence of MetS in persons with T2DM, thus calling for a routine screening of MetS in persons with theT2DM. Secondly, FDR of subjects with T2DM are increasingly being diagnosed with MetS and FDRs of T2DM patients constitute a high-risk group for DM. Th erefore, a national campaign on the need to embrace positive lifestyle measures will help reduce the prevalence of MetS in T2DM patients and their FDRs.
